Human APOH/B2G1/B2GP1 ORF/cDNA clone-Lentivirus plasmid (NM_000042)
Cat. No.: pGMLP000456
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human APOH/B2G1/B2GP1 Lentiviral expression plasmid for APOH lentivirus packaging, APOH lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
APOH/B2G1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLP000456 |
Gene Name | APOH |
Accession Number | NM_000042 |
Gene ID | 350 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 1038 bp |
Gene Alias | B2G1,B2GP1,BG |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGATTTCTCCAGTGCTCATCTTGTTCTCGAGTTTTCTCTGCCATGTTGCTATTGCAGGACGGACCTGTCCCAAGCCAGATGATTTACCATTTTCCACAGTGGTCCCGTTAAAAACATTCTATGAGCCAGGAGAAGAGATTACGTATTCCTGCAAGCCGGGCTATGTGTCCCGAGGAGGGATGAGAAAGTTTATCTGCCCTCTCACAGGACTGTGGCCCATCAACACTCTGAAATGTACACCCAGAGTATGTCCTTTTGCTGGAATCTTAGAAAATGGAGCCGTACGCTATACGACTTTTGAATATCCCAACACGATCAGTTTTTCTTGTAACACTGGGTTTTATCTGAATGGCGCTGATTCTGCCAAGTGCACTGAGGAAGGAAAATGGAGCCCGGAGCTTCCTGTCTGTGCTCCCATCATCTGCCCTCCACCATCCATACCTACGTTTGCAACACTTCGTGTTTATAAGCCATCAGCTGGAAACAATTCCCTCTATCGGGACACAGCAGTTTTTGAATGTTTGCCACAACATGCGATGTTTGGAAATGATACAATTACCTGCACGACACATGGAAATTGGACTAAATTACCAGAATGCAGGGAAGTAAAATGCCCATTCCCATCAAGACCAGACAATGGATTTGTGAACTATCCTGCAAAACCAACACTTTATTACAAGGATAAAGCCACATTTGGCTGCCATGATGGATATTCTCTGGATGGCCCGGAAGAAATAGAATGTACCAAACTGGGAAACTGGTCTGCCATGCCAAGTTGTAAAGCATCTTGTAAAGTACCTGTGAAAAAAGCCACTGTGGTGTACCAAGGAGAGAGAGTAAAGATTCAGGAAAAATTTAAGAATGGAATGCTACATGGTGATAAAGTTTCTTTCTTCTGCAAAAATAAGGAAAAGAAGTGTAGCTATACAGAGGATGCTCAGTGTATAGATGGCACTATCGAAGTCCCCAAATGCTTCAAGGAACACAGTTCTCTGGCTTTTTGGAAAACTGATGCATCCGATGTAAAGCCATGCTAA |
ORF Protein Sequence | MISPVLILFSSFLCHVAIAGRTCPKPDDLPFSTVVPLKTFYEPGEEITYSCKPGYVSRGGMRKFICPLTGLWPINTLKCTPRVCPFAGILENGAVRYTTFEYPNTISFSCNTGFYLNGADSAKCTEEGKWSPELPVCAPIICPPPSIPTFATLRVYKPSAGNNSLYRDTAVFECLPQHAMFGNDTITCTTHGNWTKLPECREVKCPFPSRPDNGFVNYPAKPTLYYKDKATFGCHDGYSLDGPEEIECTKLGNWSAMPSCKASCKVPVKKATVVYQGERVKIQEKFKNGMLHGDKVSFFCKNKEKKCSYTEDAQCIDGTIEVPKCFKEHSSLAFWKTDASDVKPC |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T86885-Ab | Anti-APOH/ B2G1/ B2GP1 functional antibody |
Target Antigen | GM-Tg-g-T86885-Ag | APOH protein |
ORF Viral Vector | pGMLP000456 | Human APOH Lentivirus plasmid |
ORF Viral Vector | pGMAP000271 | Human APOH Adenovirus plasmid |
ORF Viral Vector | vGMLP000456 | Human APOH Lentivirus particle |
ORF Viral Vector | vGMAP000271 | Human APOH Adenovirus particle |
Target information
Target ID | GM-T86885 |
Target Name | APOH |
Gene Group Identifier (Target Gene ID in Homo species) |
350 |
Gene ID |
100063250 (Equus caballus), 101080593 (Felis catus), 11818 (Mus musculus), 281006 (Bos taurus) 287774 (Rattus norvegicus), 350 (Homo sapiens), 403945 (Canis lupus familiaris), 718645 (Macaca mulatta) |
Gene Symbols & Synonyms | APOH,Apoh,B2GPI,beta2-GPI,beta-2-GPI,BG,B2G1,B2GP1 |
Target Alternative Names | APOH,Beta-2-glycoprotein 1,APC inhibitor, Activated protein C-binding protein, Anticardiolipin cofactor, Apolipoprotein H (Apo-H), Beta-2-glycoprotein I (B2GPI, Beta(2)GPI),BG,B2G1,B2GP1 |
Uniprot Accession |
P02749,P17690,P26644,P33703,Q01339
Additional SwissProt Accessions: Q01339,P17690,P26644,P02749,P33703 |
Uniprot Entry Name | |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target |
Disease | |
Disease from KEGG | Cholesterol metabolism |
Gene Ensembl | ENSECAG00000022165, ENSMUSG00000000049, ENSBTAG00000001915, ENSG00000091583, ENSCAFG00845028150, ENSMMUG00000015120 |
Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.